Key facts
- This page summarizes Stuart Diamond's Form 4 filing for bioAffinity Technologies, Inc. (BIAF).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Jan 2024, 20:52.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Award
Additional SEC filing notes
Footnote F1
Represents a grant from the Issuer to Mr. Diamond of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
Footnote F2
Represents a grant from the Issuer to Mr. Diamond of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year
SEC remarks
Exhibit List: Exhibit 24.1 - Power of Attorney (Stuart Diamond)